KRISTALL EINER BENZIMIDAZOLVERBINDUNG

European patent · EP2262790 · In force

Register entry

Publication number
EP2262790
Application number
EP09719483
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 9, 2009
Published
Dec 22, 2010
Granted
Jun 7, 2017
Protection ends at the latest
Mar 8, 2029
Next annual fee due
Mar 31, 2027
IPC classes
C07D 401/12 (2006.01)
A61K 31/4439 (2006.01)
A61P 1/04 (2006.01)
Priority
JP 2008059342 10.03.2008
PCT application
PCT/JP2009/054970 09.03.2009
PCT publication
WO2009/113696 17.09.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Jul 6, 2017

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 06.07.2017

  6. Jun 7, 2017

    Granted

    Published in Swissreg on 07.06.2017

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku Osaka-shi, Osaka 541-0045, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

HASHIMOTO, Hideo

Yamaguchi 743-8502, JP

URAI, Tadashi

Osaka-shi Osaka 532-8686, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.